$XENT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intersect ENT, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intersect ENT, Inc.. Get notifications about new insider transactions in Intersect ENT, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Option Exercise | A | 16.50 | 5,734 | 94,611 | 5,734 | ||
Jun 07 2021 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Grant | A | 0.00 | 3,239 | 0 | 12,076 | 8.8 K to 12.1 K (+36.65 %) | |
Apr 07 2021 | XENT | Intersect ENT, Inc ... | Sandoval Elisabeth | Option Exercise | A | 20.98 | 15,896 | 333,498 | 15,896 | ||
Mar 29 2021 | XENT | Intersect ENT, Inc ... | Hattangadi Neil A | Option Exercise | A | 21.44 | 13,993 | 300,010 | 13,993 | ||
Mar 18 2021 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Option Exercise | A | 21.00 | 3,390 | 71,190 | 3,390 | ||
Mar 18 2021 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 21.00 | 3,390 | 71,190 | 3,390 | ||
Mar 18 2021 | XENT | Intersect ENT, Inc ... | Lucchese Cynthia L | Option Exercise | A | 21.00 | 3,390 | 71,190 | 3,390 | ||
Feb 08 2021 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | EVP & Chief Operati ... | Payment of Exercise | F | 24.16 | 1,227 | 29,646 | 41,042 | 42.3 K to 41 K (-2.90 %) |
Feb 08 2021 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Payment of Exercise | F | 24.16 | 5,013 | 121,121 | 278,047 | 283.1 K to 278 K (-1.77 %) |
Feb 05 2021 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Option Exercise | M | 0.72 | 12,500 | 9,000 | 0 | ||
Feb 05 2021 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Buy | M | 0.72 | 12,500 | 9,000 | 260,961 | 248.5 K to 261 K (+5.03 %) | |
Feb 03 2021 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | EVP & Chief Operati ... | Option Exercise | A | 23.07 | 29,750 | 686,333 | 29,750 | |
Feb 03 2021 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | EVP & Chief Operati ... | Grant | A | 0.00 | 15,234 | 0 | 42,269 | 27 K to 42.3 K (+56.35 %) |
Feb 03 2021 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Option Exercise | A | 23.07 | 34,000 | 784,380 | 34,000 | |
Feb 03 2021 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Grant | A | 0.00 | 17,411 | 0 | 135,533 | 118.1 K to 135.5 K (+14.74 %) |
Feb 03 2021 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 23.07 | 118,461 | 2,732,895 | 118,461 | |
Feb 03 2021 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 62,500 | 0 | 283,060 | 220.6 K to 283.1 K (+28.34 %) |
Jan 06 2021 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Payment of Exercise | F | 22.81 | 1,416 | 32,303 | 14,790 | 16.2 K to 14.8 K (-8.74 %) |
Dec 04 2020 | XENT | Intersect ENT, Inc ... | BRODERICK PATRICK A | EVP, GC & Corporate ... | Option Exercise | A | 19.89 | 44,989 | 894,831 | 44,989 | |
Dec 04 2020 | XENT | Intersect ENT, Inc ... | BRODERICK PATRICK A | EVP, GC & Corporate ... | Grant | A | 0.00 | 24,156 | 0 | 24,156 | 0 to 24.2 K |
Dec 04 2020 | XENT | Intersect ENT, Inc ... | Fernandez Reyna M | Chief Human Resourc ... | Option Exercise | A | 19.89 | 29,993 | 596,561 | 29,993 | |
Dec 04 2020 | XENT | Intersect ENT, Inc ... | Fernandez Reyna M | Chief Human Resourc ... | Grant | A | 0.00 | 16,104 | 0 | 16,104 | 0 to 16.1 K |
Dec 01 2020 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Payment of Exercise | F | 20.00 | 6,349 | 127,003 | 118,122 | 124.5 K to 118.1 K (-5.10 %) |
Jul 27 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Payment of Exercise | F | 17.53 | 16,830 | 295,094 | 220,060 | 236.9 K to 220.1 K (-7.10 %) |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | Mead Dana G Jr. | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | Mead Dana G Jr. | Grant | A | 0.00 | 5,011 | 0 | 20,890 | 15.9 K to 20.9 K (+31.56 %) | |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Grant | A | 0.00 | 5,011 | 0 | 248,461 | 243.5 K to 248.5 K (+2.06 %) | |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Grant | A | 0.00 | 5,011 | 0 | 8,837 | 3.8 K to 8.8 K (+130.97 %) | |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | VERNON W ANTHONY | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | VERNON W ANTHONY | Grant | A | 0.00 | 5,011 | 0 | 11,383 | 6.4 K to 11.4 K (+78.64 %) | |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | Lucchese Cynthia L | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | Lucchese Cynthia L | Grant | A | 0.00 | 5,011 | 0 | 16,383 | 11.4 K to 16.4 K (+44.06 %) | |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Grant | A | 0.00 | 5,011 | 0 | 34,273 | 29.3 K to 34.3 K (+17.12 %) | |
Mar 18 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Buy | P | 8.48 | 19,035 | 161,434 | 236,890 | 217.9 K to 236.9 K (+8.74 %) |
Mar 17 2020 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Buy | P | 7.80 | 5,000 | 38,997 | 124,471 | 119.5 K to 124.5 K (+4.19 %) |
Mar 17 2020 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Buy | P | 13.75 | 2,500 | 34,375 | 119,471 | 117 K to 119.5 K (+2.14 %) |
Mar 17 2020 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Buy | P | 13.50 | 2,500 | 33,750 | 116,971 | 114.5 K to 117 K (+2.18 %) |
Mar 17 2020 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Buy | P | 12.75 | 2,500 | 31,875 | 114,471 | 112 K to 114.5 K (+2.23 %) |
Mar 17 2020 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Buy | P | 10.19 | 2,500 | 25,463 | 111,971 | 109.5 K to 112 K (+2.28 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Option Exercise | A | 26.18 | 13,250 | 346,885 | 13,250 | |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Grant | A | 0.00 | 6,690 | 0 | 31,086 | 24.4 K to 31.1 K (+27.42 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Grant | A | 0.00 | 6,690 | 0 | 24,396 | 17.7 K to 24.4 K (+37.78 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operating Off ... | Option Exercise | A | 26.18 | 19,250 | 503,965 | 19,250 | |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operating Off ... | Grant | A | 0.00 | 9,720 | 0 | 27,035 | 17.3 K to 27 K (+56.14 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operating Off ... | Grant | A | 0.00 | 9,720 | 0 | 17,315 | 7.6 K to 17.3 K (+127.98 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Option Exercise | A | 26.18 | 21,870 | 572,557 | 21,870 | |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Grant | A | 0.00 | 11,040 | 0 | 38,332 | 27.3 K to 38.3 K (+40.45 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Grant | A | 0.00 | 11,040 | 0 | 27,292 | 16.3 K to 27.3 K (+67.93 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Option Exercise | A | 26.18 | 21,270 | 556,849 | 21,270 | |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Grant | A | 0.00 | 10,740 | 0 | 79,205 | 68.5 K to 79.2 K (+15.69 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Grant | A | 0.00 | 10,740 | 0 | 68,465 | 57.7 K to 68.5 K (+18.61 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 26.18 | 78,700 | 2,060,366 | 78,700 | |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 39,700 | 0 | 217,855 | 178.2 K to 217.9 K (+22.28 %) |
Feb 05 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 39,700 | 0 | 178,155 | 138.5 K to 178.2 K (+28.67 %) |
Jan 22 2020 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Option Exercise | A | 24.45 | 3,355 | 82,030 | 3,355 | ||
Jan 22 2020 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Option Exercise | A | 24.45 | 3,355 | 82,030 | 3,355 | ||
Jan 06 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Payment of Exercise | F | 24.27 | 2,068 | 50,187 | 17,706 | 19.8 K to 17.7 K (-10.46 %) |
Jan 06 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Payment of Exercise | F | 24.23 | 4,357 | 105,567 | 19,774 | 24.1 K to 19.8 K (-18.06 %) |
Jan 06 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operations Of ... | Payment of Exercise | F | 24.15 | 4,357 | 105,207 | 7,595 | 12 K to 7.6 K (-36.45 %) |
Jan 06 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Payment of Exercise | F | 24.27 | 658 | 15,969 | 16,252 | 16.9 K to 16.3 K (-3.89 %) |
Jan 06 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Payment of Exercise | F | 24.23 | 3,792 | 91,878 | 16,910 | 20.7 K to 16.9 K (-18.32 %) |
Jan 06 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Payment of Exercise | F | 24.27 | 3,459 | 83,945 | 57,725 | 61.2 K to 57.7 K (-5.65 %) |
Jan 06 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Payment of Exercise | F | 24.23 | 4,357 | 105,567 | 61,184 | 65.5 K to 61.2 K (-6.65 %) |
Nov 29 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Grant | A | 0.00 | 31,794 | 0 | 65,541 | 33.7 K to 65.5 K (+94.21 %) |
Nov 29 2019 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Option Exercise | A | 21.60 | 74,852 | 1,616,803 | 74,852 | |
Nov 29 2019 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Grant | A | 0.00 | 57,230 | 0 | 109,471 | 52.2 K to 109.5 K (+109.55 %) |
Nov 29 2019 | XENT | Intersect ENT, Inc ... | MEIER RICHARD A | EVP & Chief Financi ... | Grant | A | 0.00 | 52,241 | 0 | 52,241 | 0 to 52.2 K |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Option Exercise | M | 13.05 | 7,875 | 102,769 | 7,000 | |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Option Exercise | M | 18.90 | 9,375 | 177,188 | 1,042 | |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Option Exercise | M | 21.06 | 4,687 | 98,708 | 0 | |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Sell | S | 21.54 | 25,584 | 551,069 | 20,702 | 46.3 K to 20.7 K (-55.27 %) |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Buy | M | 13.05 | 7,875 | 102,769 | 46,286 | 38.4 K to 46.3 K (+20.50 %) |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Buy | M | 18.90 | 9,375 | 177,188 | 38,411 | 29 K to 38.4 K (+32.29 %) |
Nov 07 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Buy | M | 21.06 | 4,687 | 98,708 | 29,036 | 24.3 K to 29 K (+19.25 %) |
Oct 02 2019 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Executive Chairman | Option Exercise | A | 17.01 | 82,387 | 1,401,403 | 82,387 | |
Oct 02 2019 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Executive Chairman | Grant | A | 0.00 | 17,202 | 0 | 29,262 | 12.1 K to 29.3 K (+142.64 %) |
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 1.20 | 48,333 | 58,000 | 48,333 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 1.20 | 48,333 | 58,000 | 0 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 13.05 | 45,500 | 593,775 | 45,500 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 13.05 | 45,500 | 593,775 | 0 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 18.90 | 196,875 | 3,720,938 | 196,875 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 18.90 | 196,875 | 3,720,938 | 0 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 21.06 | 150,000 | 3,159,000 | 150,000 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 21.06 | 150,000 | 3,159,000 | 0 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 28.58 | 19,688 | 562,683 | 19,688 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 28.58 | 19,688 | 562,683 | 0 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 33.95 | 44,625 | 1,515,019 | 44,625 | ||
Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 33.95 | 44,625 | 1,515,019 | 0 | ||
Jul 24 2019 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 20.44 | 427,147 | 8,730,885 | 427,147 | |
Jul 24 2019 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 20.44 | 427,147 | 8,730,885 | 427,147 | |
Jul 24 2019 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 20.44 | 97,960 | 2,002,302 | 97,960 | |
Jul 24 2019 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 20.44 | 97,960 | 2,002,302 | 97,960 | |
Jul 24 2019 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 138,455 | 0 | 138,455 | 0 to 138.5 K |
Jul 24 2019 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 138,455 | 0 | 138,455 | 0 to 138.5 K |
Jun 17 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Option Exercise | M | 13.05 | 350 | 4,568 | 6,550 | |
Jun 17 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Sell | S | 25.00 | 350 | 8,750 | 35,982 | 36.3 K to 36 K (-0.96 %) |
Jun 17 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Buy | M | 13.05 | 350 | 4,568 | 36,332 | 36 K to 36.3 K (+0.97 %) |
Jun 06 2019 | XENT | Intersect ENT, Inc ... | Mead Dana G Jr. | Option Exercise | A | 23.02 | 5,172 | 119,059 | 5,172 | ||
Jun 06 2019 | XENT | Intersect ENT, Inc ... | Mead Dana G Jr. | Grant | A | 0.00 | 2,312 | 0 | 15,879 | 13.6 K to 15.9 K (+17.04 %) | |
Jun 06 2019 | XENT | Intersect ENT, Inc ... | VERNON W ANTHONY | Option Exercise | A | 23.02 | 5,172 | 119,059 | 5,172 | ||
Jun 06 2019 | XENT | Intersect ENT, Inc ... | VERNON W ANTHONY | Grant | A | 0.00 | 2,312 | 0 | 6,372 | 4.1 K to 6.4 K (+56.95 %) | |
Jun 06 2019 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Option Exercise | A | 23.02 | 5,172 | 119,059 | 5,172 | ||
Jun 06 2019 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Grant | A | 0.00 | 2,312 | 0 | 243,450 | 241.1 K to 243.5 K (+0.96 %) | |
Jun 06 2019 | XENT | Intersect ENT, Inc ... | Lucchese Cynthia L | Option Exercise | A | 23.02 | 5,172 | 119,059 | 5,172 | ||
Jun 06 2019 | XENT | Intersect ENT, Inc ... | Lucchese Cynthia L | Grant | A | 0.00 | 2,312 | 0 | 11,372 | 9.1 K to 11.4 K (+25.52 %) | |
Jun 06 2019 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Option Exercise | A | 23.02 | 5,172 | 119,059 | 5,172 | ||
Jun 06 2019 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Grant | A | 0.00 | 2,312 | 0 | 3,826 | 1.5 K to 3.8 K (+152.71 %) | |
May 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Option Exercise | M | 13.05 | 9,500 | 123,975 | 140,000 | |
May 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Sell | S | 25.59 | 9,500 | 243,102 | 421,983 | 431.5 K to 422 K (-2.20 %) |
May 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Buy | M | 13.05 | 9,500 | 123,975 | 431,483 | 422 K to 431.5 K (+2.25 %) |
May 14 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Option Exercise | M | 13.05 | 5,350 | 69,818 | 6,900 | |
May 14 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Sell | S | 27.38 | 5,350 | 146,498 | 35,982 | 41.3 K to 36 K (-12.94 %) |
May 14 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Buy | M | 13.05 | 5,350 | 69,818 | 41,332 | 36 K to 41.3 K (+14.87 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Executive Chairman | Option Exercise | A | 25.10 | 180,096 | 4,520,410 | 180,096 | |
May 08 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Option Exercise | M | 18.00 | 9,000 | 162,000 | 76,000 | |
May 08 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Grant | A | 0.00 | 11,952 | 0 | 33,747 | 21.8 K to 33.7 K (+54.84 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Sell | S | 33.02 | 9,000 | 297,202 | 21,795 | 30.8 K to 21.8 K (-29.23 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Buy | M | 18.00 | 9,000 | 162,000 | 30,795 | 21.8 K to 30.8 K (+41.29 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Grant | A | 0.00 | 11,952 | 0 | 43,836 | 31.9 K to 43.8 K (+37.49 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Grant | A | 0.00 | 11,952 | 0 | 23,849 | 11.9 K to 23.8 K (+100.46 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Grant | A | 0.00 | 11,952 | 0 | 24,131 | 12.2 K to 24.1 K (+98.14 %) |
May 08 2019 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operations Of ... | Grant | A | 0.00 | 11,952 | 0 | 11,952 | 0 to 12 K |
May 08 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Grant | A | 0.00 | 11,952 | 0 | 35,982 | 24 K to 36 K (+49.74 %) |
May 01 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Option Exercise | M | 18.00 | 9,000 | 162,000 | 85,000 | |
May 01 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Sell | S | 33.04 | 9,000 | 297,343 | 21,795 | 30.8 K to 21.8 K (-29.23 %) |
May 01 2019 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Buy | M | 18.00 | 9,000 | 162,000 | 30,795 | 21.8 K to 30.8 K (+41.29 %) |
May 01 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Option Exercise | M | 21.06 | 12,500 | 263,250 | 0 | |
May 01 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Sell | S | 31.06 | 12,500 | 388,250 | 24,030 | 36.5 K to 24 K (-34.22 %) |
May 01 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Buy | M | 21.06 | 12,500 | 263,250 | 36,530 | 24 K to 36.5 K (+52.02 %) |
Apr 24 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Sell | S | 30.00 | 2,663 | 79,890 | 43,115 | 45.8 K to 43.1 K (-5.82 %) |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Option Exercise | M | 1.20 | 6,016 | 7,219 | 48,333 | |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Option Exercise | M | 13.05 | 7,500 | 97,875 | 149,500 | |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Sell | S | 28.43 | 29,588 | 841,243 | 421,983 | 451.6 K to 422 K (-6.55 %) |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Buy | M | 1.20 | 6,016 | 7,219 | 451,571 | 445.6 K to 451.6 K (+1.35 %) |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Buy | M | 13.05 | 7,500 | 97,875 | 445,555 | 438.1 K to 445.6 K (+1.71 %) |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Option Exercise | M | 1.20 | 6,016 | 7,219 | 48,333 | |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Option Exercise | M | 13.05 | 7,500 | 97,875 | 149,500 | |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Sell | S | 28.43 | 29,588 | 841,243 | 421,983 | 451.6 K to 422 K (-6.55 %) |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Buy | M | 1.20 | 6,016 | 7,219 | 451,571 | 445.6 K to 451.6 K (+1.35 %) |
Apr 17 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Buy | M | 13.05 | 7,500 | 97,875 | 445,555 | 438.1 K to 445.6 K (+1.71 %) |
Apr 12 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Option Exercise | M | 18.90 | 10,000 | 189,000 | 15,000 | |
Apr 12 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Sell | S | 29.13 | 10,000 | 291,318 | 45,778 | 55.8 K to 45.8 K (-17.93 %) |
Apr 12 2019 | XENT | Intersect ENT, Inc ... | Stimson Susan P | Chief Strategy Offi ... | Buy | M | 18.90 | 10,000 | 189,000 | 55,778 | 45.8 K to 55.8 K (+21.84 %) |
Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 13.05 | 4,709 | 61,452 | 30,625 | |
Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 18.90 | 16,491 | 311,680 | 58,509 | |
Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 13.05 | 30,000 | 391,500 | 35,334 | |
Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 32.34 | 4,709 | 152,299 | 31,884 | 36.6 K to 31.9 K (-12.87 %) |